Autor: |
Tanaka E; Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.; Department of Internal Medicine, Fukuyama City Hospital, Japan., Oda N; Department of Internal Medicine, Fukuyama City Hospital, Japan., Ogawa T; Department of Internal Medicine, Fukuyama City Hospital, Japan., Takata I; Department of Internal Medicine, Fukuyama City Hospital, Japan., Terao M; Department of Internal Medicine, Fukuyama City Hospital, Japan., Ueki T; Department of Internal Medicine, Fukuyama City Hospital, Japan. |
Jazyk: |
angličtina |
Zdroj: |
Internal medicine (Tokyo, Japan) [Intern Med] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08. |
DOI: |
10.2169/internalmedicine.3988-24 |
Abstrakt: |
A 56-year-old man presented to our hospital with dyspnea on exertion for two months. Bilateral pleural effusions were found, and a close examination revealed a chylothorax, including adenocarcinoma. The primary tumor could not be identified by systemic examination. Therefore, the patient was diagnosed with cancer of unknown primary origin (CUP) presenting with chylothorax. Chemotherapy was administered for CUP, and thoracentesis, pleurodesis, ascites puncture, and nutritional therapy were performed for chylothorax and chylous ascites. Although drainage frequency and tumor marker levels (CA19-9, DUPAN-2, and Span-1) temporarily decreased, disease control deteriorated, and the patient died 12 months after the initial diagnosis. |
Databáze: |
MEDLINE |
Externí odkaz: |
|